RDUS Radius Health Inc.

18.37
-0.55  -3%
Previous Close 18.92
Open 18.92
Price To Book 13.81
Market Cap 840430586
Shares 45,750,168
Volume 179,276
Short Ratio
Av. Daily Volume 556,732

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 trial initiation announced March 31, 2018.
TYMLOS Abaloparatide-SC
Male Osteoporosis
Phase 3 data 2021.
Elacestrant - EMERALD
Breast cancer
PDUFA date originally scheduled for March 30 2017 delayed by three months to June 30, 2017. Approval announced April 28, 2017.
TYMLOS (Abaloparatide)
Osteoporosis
Phase 1 dose-expansion cohort to be initiated mid-2019.
AB122
Solid tumors
Phase 3 trial to be initiated mid-2019.
Abaloparatide -Transdermal Patch
Osteoporosis
Phase 1 trial presentation at SABCS December 2018.
RAD140
Breast cancer

Latest News

  1. Radius Health Presents Analysis from Phase 3 ACTIVE Trial and Data from Preclinical Studies for TYMLOS® (abaloparatide) Injection at ENDO 2019 Annual Meeting
  2. Radius Health to Present Data on TYMLOS® (abaloparatide) Injection at ENDO 2019 Annual Meeting
  3. Edited Transcript of RDUS earnings conference call or presentation 28-Feb-19 9:30pm GMT
  4. See what the IHS Markit Score report has to say about Radius Health Inc.
  5. Radius Health to Present at Cowen 39th Annual Healthcare Conference
  6. Did You Manage To Avoid Radius Health’s (NASDAQ:RDUS) 48% Share Price Drop?
  7. Radius (RDUS) Posts Narrower Q4 Loss on Robust Tymlos Sales
  8. Radius Health to Participate in 2019 Credit Suisse Global Healthcare Conference
  9. Radius Health Inc (RDUS) Q4 2018 Earnings Conference Call Transcript
  10. Radius Health Announces Fourth Quarter and Full-Year 2018 Operating Results
  11. Radius Health to Present at Leerink Partners 8th Annual Global Healthcare Conference
  12. Radius Health to Announce Fourth Quarter and Full Year 2018 Financial Results, Host Conference Call and Live Webcast on Thursday, February 28, 2019
  13. Detailed Research: Economic Perspectives on Edwards Lifesciences, Zimmer Biomet, American Outdoor Brands, Radius Health, Kaman, and FARO Technologies — What Drives Growth in Today's Competitive Landscape
  14. Radius Health Appoints Jessica Hopfield, Ph.D., to Board of Directors
  15. How Does Radius Health, Inc. (NASDAQ:RDUS) Affect Your Portfolio Volatility?
  16. Radius Exceeds 2018 Financial Guidance, Provides Updates